Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Early diagnosis and personalized treatment are crucial for managing different types of alopecia effectively.

High-fructose diets can cause irreversible kidney damage.

Gut bacteria differences could help diagnose and treat alopecia areata.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Juvenile alopecia areata is more severe and has a worse prognosis than maturity-onset alopecia areata.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Oxidative stress is linked to mild patchy alopecia areata.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

The document provides 70 multiple choice questions to improve haematology skills.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Hair evaluation is crucial for early diagnosis and management of ARCI, as hair loss often indicates severity.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

The new model helps understand and develop treatments for genetic skin disorders like AEC.

Eosinophilic esophagitis may trigger alopecia areata in some patients.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.